Transcriptional inhibition of p53 by the MLL/MEN chimeric protein found in myeloid leukemia

Blood

Volumn 93, Issue 10, 1999, Pages 3216-3224

  Maki, Kazuhiro ^a   Mitani, Kinuko ^a   Yamagata, Tetsuya ^a   Kurokawa, Mineo ^a   Kanda, Yoshinobu ^a   Yazaki, Yoshio ^a   Hirai, Hisamaru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; ELONGATION FACTOR; LUCIFERASE; PROTEIN MEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MLL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CHROMOSOME TRANSLOCATION 11; CONTROLLED STUDY; LEUKEMOGENESIS; MOLECULAR DYNAMICS; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0033562638     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.10.3216.410k45_3216_3224     Document Type: Article

References (44)

1. Rowley JD: Recurring chromosome abnormalities in leukemia and lymphoma. Semin Hematol 27:122, 1990
2. Rubnitz JE, Behm FG, Downing JR: 11q23 rearrangements in acute leukemia. Leukemia 10:74, 1996
3. Tkachuk DC, Kohler S, Cleary ML: Involvement of a homolog of Drosophila Trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71:691, 1992
4. Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G, Croce CM, Canaani E: The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 71:701, 1992
5. Nakamura T, Alder H, Gu Y, Prasad R, Canaani O, Kamada N, Gale RP, Lange B, Crist WM Nowell PC, Croce CM, Canaani E: Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc Natl Acad Sci US A 90:4631, 1993
6. Prasad R, Leshkowitz D, Gu Y, Alder H, Nakamura T, Saito H, Huebner K, Berger R, Croce CM, Canaani E: Leucine-zipper dimerization motif encoded by the AF17 gene fused to ALL-1(MLL) in acute leukemia. Proc Natl Acad Sci USA 90:8107, 1994
7. Chaplin T, Ayton P, Bernard OA, Saha V, Valle VD, Hilliton J, Gregorini A, Lillington D, Berger R, Young BD: A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukemia. Blood 85:1435, 1995
8. So CW, Caldas C, Liu MM, Chen SJ, Huang QH, Gu LJ, Sham MH, Wiedemann LM, Chan LC: EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemia. Proc Natl Acad Sci USA 94:2563, 1997
9. Mitani K, Kanda Y, Ogawa S, Tanaka T, Inazawa J, Yazaki Y, Hirai H: Cloning of several species of MLL/MEN chimeric cDNAs in myeloid leukemia with t(11;19)(q23;p13.1) translocation. Blood 85: 2017, 1995
10. Thirman MJ, Levitan DA, Kobayashi H, Simon MC, Rowley JD: Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. Proc Natl Acad Sci USA 91:12110, 1994
11. Shilatifard A, Lane WS, Jackson KW, Conaway RC, Conaway JW: An RNA polymerase II elongation factor encoded by the human ELL gene. Science 271:1873, 1996
12. Taki T, Sako M, Tsuchida M, Hayashi Y: The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood 89:3945, 1997
13. Ida K, Kitabayashi I, Taki T, Taniwaki M, Noro K, Yamamoto M, Ohki M, Hayashi Y: Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). Blood 90:4699, 1997
14. Taki T, Hayashi Y, Taniwaki M, Seto M, Ueda R, Hanada R, Suzukawa K, Yokota J, Morishita K: Fusion of the MLL gene with two different genes, AF-6 and AF Salpha, by a complex translocation involving chromosomes 5, 6, 8 and 11 in infant leukemia. Oncogene 13:2121, 1996
15. Joh T, Yamamoto K, Kagami Y, Kakuda H, Sato T, Yamamoto T, Takahashi T, Ueda R, Kaibuchi K, Seto M: Chimeric MLL products with a Ras binding cytoplasmic protein AF6 involving in t(6;11)(q27; q23) leukemia localize in the neucleus. Oncogene 15:1681, 1997
16. Megonigal MD, Rappaport EF, Jones DH, Williams TM, Lovett BD, Kelly KM, Lerou PH, Moulton T, Budarf ML, Felix CA: t(11;22)(q23;q11.2) in acute leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velcardiofacial syndromes. Proc Natl Acad Sci USA 95:6413, 1998
17. Taki T, Shibuya N, Taniwaki M, Hanada R, Morishita K, Bessho F, Yanagisawa M, Hayashi Y: ABI-1, a human homolog to mouse Ab1-interactor 1, fuses the MLL gene in acute myeloid leukemia with t(10;11)(p11.2;q23). Blood 92:1125, 1998
18. Shilatifard A, Haque D, Conaway RC, Conaway JW: Structure and function of RNA polymerase II elongation factor ELL. Identification of two overlapping ELL functional domains that govern its interaction with polymerase and the ternary elongation complex. J Biol Chem 272:22355, 1997
19. Shilatifard A, Duan DR, Haque D, Florence C, Schubach WH, Conaway JW, Conaway RC: ELL2, a new member of an ELL family of RNA polymerase II elongation factors. Proc Natl Acad Sci USA 94:3639, 1997
20. Kanda Y, Mitani K, Tanaka T, Tanaka K, Ogawa S, Yazaki Y, Hirai H: Subcellular localization of the MEN, MLL/MEN and truncated MLL proteins expressed in leukemic cells carrying the t(11;19)(q23; p13.1) translocation. Int J Hematol 66:189, 1997
21. Kanda Y, Mitani K, Kurokawa M, Yamagata T, Yazaki Y, Hirai H: Overexpression of the MEN/ELL protein, an RNA polymerase II elongation factor, results in transformation of Rat1 cells with dependence on the lysine-rich region. J Biol Chem 273:5248, 1998
22. Hollstein M, Sidransky D, Vogelstein B, Harris C: p53 mutations in human cancers. Science 253:49, 1991
23. Fenaux P, Jonveaux P, Quiqundon I, Lai JL, Pignon JM, Loucheux-Lefebvre MH, Bauters F, Berger R, Kerckaert JP: p53 gene mutations in acute myeloid leukemia with 17p monosomy. Blood 78:1652, 1991
24. Sugimoto K, Toyoshima H, Sakai R, Miyagawa K, Hagiwara K, Hirai H, Ishikawa F, Takaku F: Mutations of the p53 gene in lymphoid leukemia. Blood 77:1153, 1991
25. Fenaux P, Jonveaux P, Quiquandon I, Preudhomme C, Lai JL, Vanrumbeke M, Loucheux-Lefebvre MH, Bauters F, Berger R, Kerchaert JP: Mutations of the p53 gene in B cell acute lymphoblastic leukemia. A report on 60 cases. Leukemia 6:42, 1992
26. Ahuja H, Bar-Eli M, Advani SH, Benchimol S, Cline MJ: Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc Natl Acad Sci USA 86:6783, 1989
27. Feinstein E, Cimino G, Gale RP, Alimena G, Berthier R, Kishi K, Goldman J, Zaccaria A, Berrebi A, Canaani E: p53 in chronic myelogenous leukemia in acute phase. Proc Natl Acad Sci USA 88:6293, 1991
28. Sugimoto K, Hirano N, Toyoshima H, Chiba S, Mano H, Takaku F, Yazaki Y, Hirai H: Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. Blood 81:3022, 1993
29. Adamson DJA, Dawson AA, Bennett B, King DJ, Haites NE: p53 mutation in the myelodysplastic syndromes. Br J Haematol 89:61, 1995
30. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75:817, 1993
31. Seto E, Usheva A, Zambetti GP, Momand J, Horikoshi N, Weinmann R, Levine AJ, Shenk T: Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc Natl Acad Sci USA 89:12028, 1992
32. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293, 1995
33. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B: Identification of p53 as a sequence-specific DNA-binding protein. Science 252:1708, 1991
34. Okamoto K, Beach D: Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J 13:4816, 1994
35. Chiu R, Angel P, Karin M: JunB differs in its biological properties from, and is a negative regulator of, c-Jun. Cell 59:979, 1989
36. Yamagata T, Nishida J, Sakai R, Tanaka T, Honda H, Hirano N, Mano H, Yazaki Y, Hirai H: Of the GATA-binding proteins, only GATA-4 selectively regulates the human interleukin-5 gene promoter in interleukin-5-producing cells which express multiple GATA-binding proteins. Mol Cell Biol 15:3830, 1995
37. Jost CA, Marin MC, Kaelin WG Jr: p73 is a human p53-related protein that can induce apoptosis. Nature 389:191, 1997
38. Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R, Prives C: Wild-type p53 activates transcription in vitro. Nature 358:83, 1992
39. Jia LQ, Osada M, Ishioka C, Gamo M, Ikawa S, Suzuki T, Shimodaira H, Niitani T, Kudo T, Akiyama M, Kimura N, Matsuo M, Mizusawa H, Tanaka N, Koyama H, Namba M, Kanamaru R, Kuroki T: Screening the p53 status of human cell lines using a yeast functional assay. Mol Carcinog 19:243, 1997
40. Kastan MB, Radin AI, Kuerbitz SJ, Onyekwere O, Wolkow CA, Civin CI, Stone KD, Woo T, Ravindranath Y, Craig RW: Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer Res 51:4279, 1991
41. Shaulsky G, Goldfinger N, Paled A, Rotter V: Involvement of wild-type p53 in pre-B-cell differentiation in vivo. Proc Natl Acad Sci USA 88:8982, 1991
42. Bi S, Lanza F, Goldman JM: The involvement of "tumor suppressor" p53 in normal and chronic myelogenous leukemia hemopoiesis. Cancer Res 54:582, 1994
43. Banerjee D, Lenz HJ, Schneiders B, Manno DJ, Ju JF, Spears CP, Hochhauser D, Danenberg K, Danenberg P, Bertino JR: Transfection of wild-type but mutant p53 induces early monocytic differenciation in HL60 cells and increases their sensitivity to stress. Cell Growth Differ 6:1405, 1995
44. Shounan Y, Dolnikov A, MacKenzie KL, Miller M, Chan YY, Symonds G: Retroviral transduction of hematopoietic progenitor cells with mutant p53 promotes survival and proliferation, modifies differentiation potential and inhibits apoptosis. Leukemia 10:1619, 1996